Literature DB >> 26397208

Quality control of cationic cell-penetrating peptides.

Sofie Stalmans1, Bert Gevaert1, Frederick Verbeke1, Matthias D'Hondt1, Nathalie Bracke1, Evelien Wynendaele1, Bart De Spiegeleer2.   

Abstract

During fundamental research, it is recommended to evaluate the test compound identity and purity in order to obtain reliable study outcomes. For peptides, quality control (QC) analyses are routinely performed using reversed-phase liquid chromatography coupled to an ultraviolet (UV) detector system. These traditional QC methods, using a C18 column and a linear gradient with formic acid (FA) as acidic modifier in the mobile phase, might not result in optimal chromatographic performance for basic peptides due to their cationic nature and hence may lead to erroneous results. Therefore, the influence of the used chromatographic system on the final QC results of basic peptides was evaluated using five cationic cell-penetrating peptides and five C18-chromatographic systems, differing in the column particle size (high performance liquid chromatography (HPLC) versus ultra-high performance liquid chromatography (UHPLC)), the acidic modifier (FA versus trifluoroacetic acid (TFA)), and the column temperature (30 °C versus 60 °C). Our results indicate that a UHPLC system with the C18 column thermostated at 30 °C and a mobile phase containing TFA, provides the most suitable routine QC analysis method for cationic peptides, outperforming in sensitivity and resolution compared to the other systems. We also demonstrate the use of a single quad mass spectrometry (MS) detector system during QC analysis of (cationic) peptides, allowing identification of the peptide and its impurities, as well as the evaluation of the peak purity.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cell-penetrating peptides; HPLC–UV; Impurity profiling; Quality control; Single quad mass Spectrometer; UHPLC–UV

Mesh:

Substances:

Year:  2015        PMID: 26397208     DOI: 10.1016/j.jpba.2015.09.011

Source DB:  PubMed          Journal:  J Pharm Biomed Anal        ISSN: 0731-7085            Impact factor:   3.935


  2 in total

1.  Cell-Penetrating Peptides Selectively Cross the Blood-Brain Barrier In Vivo.

Authors:  Sofie Stalmans; Nathalie Bracke; Evelien Wynendaele; Bert Gevaert; Kathelijne Peremans; Christian Burvenich; Ingeborgh Polis; Bart De Spiegeleer
Journal:  PLoS One       Date:  2015-10-14       Impact factor: 3.240

2.  A Quadrupole Dalton-based multi-attribute method for product characterization, process development, and quality control of therapeutic proteins.

Authors:  Weichen Xu; Rod Brian Jimenez; Rachel Mowery; Haibin Luo; Mingyan Cao; Nitin Agarwal; Irina Ramos; Xiangyang Wang; Jihong Wang
Journal:  MAbs       Date:  2017-08-14       Impact factor: 5.857

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.